Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc. is a Canadian clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for cardiovascular diseases. It operates in Canada and the United States, with a primary aim to address the unmet medical needs of patients with conditions. Operating within the Healthcare sector, Milestone Pharmaceuticals Inc. specialises in novel treatments for rapid heart conditions. Its lead product candidate, etripamil, is a novel calcium channel blocker nasal spray designed as a self-administered, rapid-response therapy. This approach aims to provide patients with convenient and effective therapeutic options for managing acute episodes outside of a clinical setting. Monitor the MIST share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.